Inhibition of analgesia by C-terminal deletion analogs of human beta-endorphin |
| |
Authors: | P Nicolas C H Li |
| |
Institution: | Laboratory of Molecular Endocrinology University of California San Francisco, CA 94143, USA |
| |
Abstract: | Human beta-endorphin (beta h-EP) analogs of variable chain lengths have been investigated for their potency in inhibiting analgesia induced by beta h-EP or by the potent opiate etorphine. It was found that beta h-EP-(1-28) inhibits the analgesic effect of beta h-EP and etorphine when co-injected intracerebroventricularly into mice. Antagonism by competition at same opioid receptor subtypes is suggested from parallel shifts of the dose-response curve of etorphine or beta h-EP in the presence of increasing doses of beta h-EP-(1-28). On a molar basis, beta h-EP-(1-28) is nearly 10 times more potent than naloxone. The reduction of the chain length from residues 1-28 to 1-27 lowered the antagonist potency while further reduction of the peptide chain led to a complete loss of inhibitory activity. From comparison of the opioid-receptor binding affinity, analgesic activity and antagonist potency, it is concluded that the C-terminus of beta-EP is critical to the biological efficacy of the molecule and that the antagonist activity of C-terminal deletion analogs is probably mediated through residues 27 and 28. |
| |
Keywords: | human beta-endorphin icv intracerebroventricularly B/A fifty percent inhibitory concentration median antinociceptive dose |
本文献已被 ScienceDirect 等数据库收录! |